Background : Although the pericentric inversion of chromosome 9, inv(9)(p11q13), is generally considered a normal variation, it is also associated with solid tumors and several hematologic malignancies such as biphenotypic acute leukemia, ALL, AML, and myeloproliferative neoplasms. However, to the best of our knowledge, there have been no reports that suggest an association between CML and constitutional pericentric inversion of chromosome 9. The purpose of this retrospective study was to investigate the frequency and clinical features of CML patients with concomitant inv(9) and t(9;22)(q34;q11.2) variation at our institution.
INTRODUCTION
Pericentric inversion of chromosome 9, inv(9)(p11q13), is inherited as a non-pathogenic variation in normal population (0.8-2%); however, this variation is also reported to be associated with predisposition to the development of solid tumors or acute leukemias (ALs). Keung et al. [1] reported that the prevalence of constitutional inv(9) variation in 799 adult AL cases was similar to that observed in the general population (0.8%). Huh et al. [2] reported that the incidence of constitutional chromosomal aberration in hematologic malignancies was similar to that of benign hematologic disorders (2.4% and 2.8%, respectively), and the inv(9) variation was frequently observed in both groups. However, the association between constitutional inv(9) variation and CML or ALL patients with Philadelphia (Ph) chromosome has been rarely documented [3] .
To our knowledge, there have been no reports on the association between CML and constitutional pericentric inv(9) variation in any ethnic group. In this study, we investigated the frequency and clinical features of Korean CML patients with concomitant inv (9) and t(9;22). (Fig. 2) . The patient was receiving imatinib mesy- 
Patient 2
A 64-yr-old man with a history of CML since July rearrangement. After 1 month, he was discharged from our hospital and referred to another regional institution.
Patient 3
A 45-yr-old man was brought to our hospital with epigastric discomfort and leukocytosis in December 2008.
CBC showed Hb level of 10.1 g/dL; platelet count of 397,000/ (Fig. 3) . The FISH analysis for BCR/ABL1
showed a "nuc ish(ABL1 × 3),(BCR × 3),(ABL1 con BCR × 2)[165/222]"karyotype. Gene rearrangement analysis for BCR/ABL1 was positive (b2a2 type) (Fig. 2) . After being diagnosed with CML in chronic phase, he was discharged 
Patient 4
A 40-yr-old woman was diagnosed with CML in chronic phase. Her chromosome analysis result in our database showed a 46,XX,t(9;22)(q34;q11.2),i (17)(q10) karyotype in 16 out of the 22 metaphase cells analyzed.
However, when we reviewed our chromosome database, we detected an additional inv(9) variation in her karyogram (Fig. 3) . Therefore, the revised karyotype of this patient was as follows: 46,XX,inv (9)(p11q13) 
DISCUSSION
There have been very few reports on the inv(9) variation as an acquired chromosomal abnormality in hematologic malignancies [4, 5] , and such variations are generally regarded as a constitutional abnormality with familial inheritance. Keung et al. [1] have reported constitutional pericentric inversion in chromosome 9 at a frequency of 0.8-2% in normal population and at a similar frequency in AL patients. Other studies reported little difference in the incidences of constitutional chromosome aberration between patients with hematologic malignancies and the general population; however, this may either be due to the low incidence of inv(9) [6] [7] [8] or the exclusion of inv(9) [9] . Although the association between inv(9) variation and CML is still a controversial topic, constitutional pericentric inv(9) may be important for predicting impaired engraftment potential of hematopoietic stem cells harboring inv(9) [10, 11] .
A careful review of literature and Mitelman database revealed that concomitant inv(9) and t(9;22) variations occurred sporadically in 8 patients [2, 3, [12] [13] [14] [15] [16] [17] , which included 4 CML patients, 3 ALL patients, and 1 acute basophilic leukemia patient (Table 1 ) [7] [8] [9] [10] [11] [12] [13] . In this study,
we analyzed the data of 70 Ph+ patients diagnosed with CML, ALL, and BAL (51, 16, and 3 patients, respectively).
The inv(9) variation was not detected in any Ph+ ALL or BAL patient, but it was detected at a relatively high frequency (7.8%) in 4 out of 51 CML patients. The detection of inv (9) is considered important in other hematologic malignancies, including ALs [1, 18, 19] . However, there have been very few studies on inv(9) detection in CML, which indicates that this variation is either overlooked or underestimated. In the fourth case in our study, we identified a previously undetected inv(9) variation as an additional chromosomal abnormality during retrospective review. Other laboratories may similarly overlook this variation partly due to neglect of its importance, and underestimate the frequency of inv (9) . In fact, in a study investigating the association between constitutional chromosomal abnormality and hematologic malignancy, the frequency of inv (9) in CML patients was observed to be 2.6% (2/77) [2] . The discrepancies in the frequencies may partly be due to the fact that the inv (9) A majority of CML patients showed significant improvement with the use of new tyrosine kinase inhibitors, but a small fraction of patients manifested multiresistance to these drugs. In such cases, additionally detected chromosomal abnormalities, whether acquired or constitutional, may partly influence the success of drug therapy or transplantation. We have suggested this possibility in the present study and our previous report [20] , and emphasized the need for identifying additional chromosomal abnormalities in patients with drug resistance.
Being a retrospective analysis, the present study was limited by a small number of patients of a single ethnic group. Hence, we could not obtain data concerning further prognosis of transplantation in CML patients with inv (9) . The underscoring finding of our study was that the frequency of detecting constitutional pericentric inv (9) in Korean CML patients was not lower than that in normal population. This result suggested that constitutional chromosomal abnormalities, including inv(9), should be more cautiously in CML patients of not only
Korean population but of other ethnic groups as well. We think that the prevalence of constitutional inv(9) variation among CML patients is similar or slightly higher than that in the general population, although further studies in this regard are required. Therefore, on the basis of the results of our study and literature review, we propose that cytogenetic analysis should involve detection of constitutional inv(9) variation in CML patients.
